Michael Cherny
Stock Analyst at UBS
(2.31)
# 1,385
Out of 4,555 analysts
79
Total ratings
46.27%
Success rate
-3.88%
Average return
Main Sectors:
Stocks Rated by Michael Cherny
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MCK McKesson | Maintains: Outperform | $670 → $665 | $509.42 | +30.54% | 5 | Sep 5, 2024 | |
| PDCO Patterson Companies | Maintains: Neutral | $27 → $24 | $20.48 | +17.19% | 8 | Sep 5, 2024 | |
| NVST Envista Holdings | Maintains: Buy | $22 → $19 | $16.98 | +11.90% | 5 | Aug 8, 2024 | |
| PGNY Progyny | Downgrades: Market Perform | $31 → $25 | $23.54 | +6.20% | 4 | Aug 7, 2024 | |
| RCM R1 RCM | Downgrades: Market Perform | $17 → $14 | $14.04 | +1.85% | 4 | Aug 1, 2024 | |
| COR Cencora | Maintains: Outperform | $275 | $236.53 | +16.26% | 2 | Jun 27, 2024 | |
| HIMS Hims & Hers Health | Maintains: Buy | $22 → $26 | $13.97 | +86.11% | 6 | Jun 13, 2024 | |
| CVS CVS Health | Maintains: Buy | $95 → $77 | $56.47 | +36.36% | 7 | May 2, 2024 | |
| BOLD Boundless Bio | Initiates: Outperform | $25 | $3.20 | +681.25% | 1 | Apr 22, 2024 | |
| WBA Walgreens Boots Alliance | Maintains: Market Perform | $23 → $22 | $8.91 | +146.91% | 2 | Mar 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $135 | $154.29 | -12.50% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $290 | $240.87 | +20.40% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $125 | $112.80 | +10.82% | 4 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $260 | $226.91 | +14.58% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $23 | $19.70 | +14.21% | 5 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8 | $7.82 | +2.30% | 4 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $32 | $36.93 | -13.35% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $19 | $11.47 | +65.65% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $42 | $25.36 | +65.62% | 3 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $310 | $221.38 | +40.03% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $78 | $68.89 | +13.22% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $16 | $4.05 | +295.06% | 6 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $17 | $7.19 | +136.44% | 1 | Feb 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underperform | $113 → $53 | $7.59 | +591.70% | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | n/a | $0.06 | - | 1 | Nov 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | n/a | $9.76 | - | 2 | Nov 2, 2018 |
McKesson
Sep 5, 2024
Maintains: Outperform
Price Target: $670 → $665
Current: $509.42
Upside: +30.54%
Patterson Companies
Sep 5, 2024
Maintains: Neutral
Price Target: $27 → $24
Current: $20.48
Upside: +17.19%
Envista Holdings
Aug 8, 2024
Maintains: Buy
Price Target: $22 → $19
Current: $16.98
Upside: +11.90%
Progyny
Aug 7, 2024
Downgrades: Market Perform
Price Target: $31 → $25
Current: $23.54
Upside: +6.20%
R1 RCM
Aug 1, 2024
Downgrades: Market Perform
Price Target: $17 → $14
Current: $14.04
Upside: +1.85%
Cencora
Jun 27, 2024
Maintains: Outperform
Price Target: $275
Current: $236.53
Upside: +16.26%
Hims & Hers Health
Jun 13, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $13.97
Upside: +86.11%
CVS Health
May 2, 2024
Maintains: Buy
Price Target: $95 → $77
Current: $56.47
Upside: +36.36%
Boundless Bio
Apr 22, 2024
Initiates: Outperform
Price Target: $25
Current: $3.20
Upside: +681.25%
Walgreens Boots Alliance
Mar 18, 2024
Maintains: Market Perform
Price Target: $23 → $22
Current: $8.91
Upside: +146.91%
Feb 26, 2024
Initiates: Market Perform
Price Target: $135
Current: $154.29
Upside: -12.50%
Feb 26, 2024
Initiates: Outperform
Price Target: $290
Current: $240.87
Upside: +20.40%
Feb 26, 2024
Initiates: Outperform
Price Target: $125
Current: $112.80
Upside: +10.82%
Feb 26, 2024
Initiates: Outperform
Price Target: $260
Current: $226.91
Upside: +14.58%
Feb 26, 2024
Initiates: Market Perform
Price Target: $23
Current: $19.70
Upside: +14.21%
Feb 26, 2024
Initiates: Outperform
Price Target: $8
Current: $7.82
Upside: +2.30%
Feb 26, 2024
Initiates: Market Perform
Price Target: $32
Current: $36.93
Upside: -13.35%
Feb 26, 2024
Initiates: Market Perform
Price Target: $19
Current: $11.47
Upside: +65.65%
Feb 26, 2024
Initiates: Outperform
Price Target: $42
Current: $25.36
Upside: +65.62%
Feb 26, 2024
Initiates: Market Perform
Price Target: $310
Current: $221.38
Upside: +40.03%
Feb 26, 2024
Initiates: Market Perform
Price Target: $78
Current: $68.89
Upside: +13.22%
Feb 26, 2024
Initiates: Outperform
Price Target: $16
Current: $4.05
Upside: +295.06%
Feb 26, 2024
Initiates: Market Perform
Price Target: $17
Current: $7.19
Upside: +136.44%
Jan 5, 2022
Downgrades: Underperform
Price Target: $113 → $53
Current: $7.59
Upside: +591.70%
Nov 23, 2021
Initiates: Buy
Price Target: n/a
Current: $0.06
Upside: -
Nov 2, 2018
Maintains: Buy
Price Target: n/a
Current: $9.76
Upside: -